Sandra Ortiz‐Cuaran

<i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma

Lynnette Fernandez‐Cuesta, Dennis Plenker, Hirotaka Osada et al. · Cancer Discovery · 2014 · 283 citations · Full text

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen et al. · Nature Medicine · 2014 · 265 citations · Full text

Medicine, Cancer Biology, Co-targeting Igf-1r +7

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker et al. · Clinical Cancer Research · 2016 · 259 citations · Full text

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Jean-David Fumet, Corentin Richard, Fanny Ledys et al. · British Journal of Cancer · 2018 · 169 citations · Full text

Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach

Julian Engel, André Richters, Matthäus Getlik et al. · Journal of Medicinal Chemistry · 2015 · 112 citations · Full text

Covalent Inhibitors, Drug Target, Molecular Biology +22